The Safety and Efficacy of Roflumilast Foam in HS

Clinical trial NCT07263230 · RECRUITING

Trial details

NCT number: NCT07263230
Sponsor: Beth Israel Deaconess Medical Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hidradenitis Suppurativa (HS)

Start date: 2026-09-01
Primary completion: 2028-08-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.